Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05256069Phase 1Completed
Phase 1, randomised, double-blind trial, sponsored by University of Missouri. Primary endpoint: Forearm Blood Flow at 5 months. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05256069.